This clinical handbook translates recent guidelines for prevention of cardiovascular disease - the ESC/EAS Joint Guidelines for Management of Dyslipidaemia (2011) - to an accessible ready reference. The book differentiates lipoproteins containing apolipoproteins B or A and their role in atherosclerosis. For the clinician, the focus is on which lipids should be analysed for risk estimation, and an overview of primary, secondary and genetic causes of dyslipidaemias. The book summarises lifestyle and pharmacotherapy options for clinical management, lipid treatment targets and practical advice for treating patients.
Summary: ESC/EAS Guidelines for the management of dyslipidaemias 1. About lipoprotein metabolism 2. How do lipoproteins cause atherosclerosis? 3. Lipids in risk estimation 4. Lifestyle intervention: a fundamental first step 5. Lipid-modifying therapy: which, when and why 6. About dyslipidaemias 7. Genetic dyslipidaemias 8. Practical advice for treating dyslipidaemia